Learn More
Medchemexpress LLC Voreloxin Hydrochloride | 175519-16-1 | 99.58% | 437.90 | 50 MG

Supplier: Medchemexpress LLC HY1651850MG
Voreloxin Hydrochloride is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
- Inhibits topoisomerase II activity.
- Induces site-selective DNA DSB.
- Causes G2 arrest.
- Leads to apoptosis.
- Shows potent cytotoxic activity in AML cell lines.
- Exhibits additive or synergistic activity with cytarabine in acute leukemia cell lines.
- Reduces bone marrow cellularity in mice.
- Causes reversible decrease in myeloid and lymphoid cells in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.